Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal tau accumulation and atrophy in aging and alzheimer disease
Theresa M. Harrison, Renaud La Joie, Anne Maaß, et al.
Annals of Neurology (2018) Vol. 85, Iss. 2, pp. 229-240
Open Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 3091
Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
Bernard Hanseeuw, Rebecca A. Betensky, Heidi I.L. Jacobs, et al.
JAMA Neurology (2019) Vol. 76, Iss. 8, pp. 915-915
Open Access | Times Cited: 663
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie, Adrienne Visani, Suzanne L. Baker, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 524
Open Access | Times Cited: 475
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 448
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Jacob W. Vogel, Yasser Iturria‐Medina, Olof Strandberg, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 393
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang, Wei Wei, Ming Zhao, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2181-2192
Open Access | Times Cited: 302
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nicolai Franzmeier, Julia Neitzel, Anna Rubinski, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 262
Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 203
Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring
Wieke M. van Oostveen, Elizabeth C. M. de Lange
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2110-2110
Open Access | Times Cited: 185
The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Meichen Yu, Olaf Sporns, Andrew J. Saykin
Nature Reviews Neurology (2021) Vol. 17, Iss. 9, pp. 545-563
Open Access | Times Cited: 178
Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer’s disease
Diana Younan, Andrew J. Petkus, Keith F. Widaman, et al.
Brain (2019) Vol. 143, Iss. 1, pp. 289-302
Open Access | Times Cited: 167
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
Justin S. Sanchez, J. Alex Becker, Heidi I.L. Jacobs, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 577
Open Access | Times Cited: 167
Brain aging mechanisms with mechanical manifestations
Yana Blinkouskaya, Andreia Caçoilo, Trisha Gollamudi, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111575-111575
Open Access | Times Cited: 156
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 114
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Felicia Liana Andronie-Cioară, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1869-1869
Open Access | Times Cited: 89
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Alexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Structural progression of Alzheimer’s disease over decades: the MRI staging scheme
Vincent Planche, José V. Manjón, Boris Mansencal, et al.
Brain Communications (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 82
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Brain (2023) Vol. 146, Iss. 5, pp. 2029-2044
Open Access | Times Cited: 76
The foundation and architecture of precision medicine in neurology and psychiatry
Harald Hampel, Peng Gao, Jeffrey L. Cummings, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 3, pp. 176-198
Open Access | Times Cited: 68
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 58
Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation
Joseph Giorgio, Jenna N. Adams, Anne Maaß, et al.
Neuron (2023) Vol. 112, Iss. 4, pp. 676-686.e4
Open Access | Times Cited: 50
Defining overlooked structures reveals new associations between cortex and cognition in aging and Alzheimer's disease
Samira A. Maboudian, Ethan H. Willbrand, William J. Jagust, et al.
Journal of Neuroscience (2024), pp. e1714232024-e1714232024
Open Access | Times Cited: 17
Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease
Jazmín Alarcón‐Espósito, Nagiri Ravi Kumar, Li Gan, et al.
Neurotherapeutics (2025), pp. e00536-e00536
Open Access | Times Cited: 2
Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease
Nicolai Franzmeier, Anna Dewenter, Lukas Frontzkowski, et al.
Science Advances (2020) Vol. 6, Iss. 48
Open Access | Times Cited: 130
Page 1 - Next Page

Scroll to top